Distribution of C-reactive protein levels determined by ultrasensitive method in the healthy Hungarian population;Az ultraszenzitív módszerrel meghatározott C-reaktív fehérjekoncentráció megoszlása az egészséges magyar populációban

Orvosi Hetilap

Volumn 145, Issue 11, 2004, Pages 567-572

  Dósa, Edit ^a,e   Szabó, Attila ^a   Entz, László ^a   Selmeci, László ^a   Walentin, Szilvia ^b   Kleiber, Mónika ^b   Rugonfalvi, Kiss Szabolcs ^c,d   Hosszúfalusi, Nóra ^c,d   Füst, György ^c,d   Prohászka, Zoltán ^c,d  

^a SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^b Kútvölgyi Klinikai Tömb   (Hungary)

^c III Belgyogyaszati Klinika   (Hungary)

^d MTA Anyagcsere és Atherosclerosis Kutató Csoport ^*

^e NONE   (Hungary)

Author keywords

C reactive protein; Cardiovascular risk; Hungarian population

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; HUNGARY; LEUKOCYTE COUNT; MALE; NORMAL HUMAN; PARAMETER; POPULATION RESEARCH; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; TRIACYLGLYCEROL BLOOD LEVEL; AGE; BLOOD; BLOOD DONOR; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CROSS-SECTIONAL STUDY; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; REFERENCE VALUE; RISK FACTOR; SEX DIFFERENCE; SMOKING;

ADULT; AGE FACTORS; AGED; BLOOD DONORS; BLOOD GLUCOSE; BLOOD PRESSURE; BLOOD SEDIMENTATION; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HUNGARY; MALE; MIDDLE AGED; REFERENCE VALUES; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 2942598497     PISSN: 00306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Albert, M. A., Staggers, J., Chew, P. és mtsai: The pravastatin inflammation CRP evaluation (PRINCE): rationale and design. Am. Heart J., 2001, 141, 893-898.
2. Blake, G. J., Ridker, P. M.: Inflammatory mechanisms in atherosclerosis: from laboratory evidence to clinical application. Ital. Heart J., 2001, 2, 796-800.
3. Crisby, M., Nordin-Fredriksson, G., Shah, P. K. és mtsai: Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation, 2001, 103, 926-933.
4. Folsom, A. R., Pankow, J. S., Tracy, R. P. és mtsai: Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am. J. Cardiol., 2001, 88, 112-117.
5. Koenig, W., Torzewski, J.: C-reactive protein and atherosclerosis: quo vadis? Ital. Heart J., 2001, 2, 801-803.
6. Koenig, W., Sund, M., Froelich, M. és mtsai: C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (MONItoring trends and determinants in CArdiovascular disease) Augsberg Cohort Study, 1984 to 1992. Circulation, 1999, 99, 237-242.
7. Kuller, L. H., Tracy, R. P., Shaten, J. és mtsai: Relationship of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Am. J. Epidemiol., 1996, 144, 537-547.
8. Lagrand, W. K., Visser, C. A., Hermens, W. T. és mtsai: C-reactive protein as a cardiovascular risk factor. More than an epiphenomenon? Circulation, 1999, 100, 96-102.
9. Libby, P., Aikawa, M.: New insights into plaque stabilization by lipid lowering. Drugs, 1998, 56, 9-13, Discussion 33.
10. Libby, P., Egan, D., Skarlatos, S. és mtsai: Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation, 1997, 96, 4095-4103.
11. Libby, P., Ridker, P. M.: Novel inflammatory markers of coronary risk. Theory versus practice. Circulation, 1999, 100, 1148-1150.
12. Meier-Ewert, H. K., Ridker, P. M., Rifai, N. és mtsai: Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin. Chem., 2001, 47, 426-430.
13. Nilsson, J., Ares, M. P. S., Lindholm, M. és mtsai: Inflammation and cholesterol. Eur. Heart J. Supplements, 2002, 4 (Suppl. A), A18-A25.
14. Pearson, T. A., Mensah, G. A., Alexander, R. W. és mtsai: Markers of inflammation and cardiovascular disease. Application to clinical and public health practice. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation, 2003, 107, 499-511.
15. Pietila, K. O., Harmoinen, A., Pöyhönen, L. és mtsai: Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy. Eur. Heart J., 1993, 14, 915-919.
16. Prohaszka, Z., Duba, J., Horvath, L. és mtsai: Comparative study on antibodies to human and bacterial 60 kDa heat shock proteins in a large cohort of patients with coronary heart disease and healthy subjects. Eur. J. Clin. Invest., 2001, 31, 283-284.
17. Ridker, P. M.: C-reactive protein and risks of future myocardial infarction and thrombotic stroke. Eur. Heart J., 1998, 19, 1-3.
18. Ridker, P. M.: High-sensitivity C-reactive protein. Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation, 2001, 103, 1813-1818.
19. Ridker, P. M.: Novel risk factors and markers for coronary disease. Adv. Intern. Med., 2000, 45, 391-418.
20. Ridker, P. M.: Role of inflammatory biomarkers in prediction of coronary heart disease. Lancet, 2001, 358, 946-948.
21. Ridker, P. M., Buring, J. E., Shih, J. és mtsai: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation, 1998, 98, 731-733.
22. Ridker, P. M., Cushman, M., Stampfer, M. és mtsai: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med., 1997, 336, 973-979.
23. Ridker, P. M., Cushman, M., Stampfer, M. és mtsai: Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation, 1998, 97, 425-428.
24. Ridker, P. M., Glynn, R. J., Hennekens, C. H. és mtsai: C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation, 1998, 97, 2007-2011.
25. Ridker, P. M., Hennekens, C. H., Buring, J. E. és mtsai: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med., 2000, 342, 836-843.
26. Ridker, P. M., Rifai, N., Pfeffer, M. A. és mtsai: Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events (CARE) investigators. Circulation, 1998, 98, 839-844.
27. Rifai, N., Ridker, P. M.: High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin. Chem., 2001, 47, 403-411.
28. Roivainen, M., Viik-Kajander, M., Palosuo, T. és mtsai: Infections, inflammation, and the risk of coronary heart disease. Circulation, 2000, 101, 252-257.
29. Rosalki, S. B.: C-reactive protein. Int. J. Clin. Pract., 2001, 55, 269-270.
30. Rossi, E., Biasucci, L. M., Citterio, F. és mtsai: Risk of myocardial infarction and angina in patients with severe peripheral vascular disease. Predictive role of C-reactive protein. Circulation, 2002, 105, 800-803.
31. Selmeci, L.: C-reaktív protein: egy régi molekula új szerepben? Klin. Kísérl. Lab. Med., 2001, 28, 46-50.
32. Shrive, A. K., Cheetham, G. M. T., Holden, D. és mtsai: Three dimensional structure of human C-reactive protein. Nature Struct. Biol., 1996, 3, 346-354.
33. Steering Committee of the Physicians' Health Study Research Group: Final report of the aspirin component of the ongoing Physicians' Health Study. N. Engl. J. Med., 1989, 321, 129-135.
34. Szalai, A. J., Agrawal, A., Greenhough, T. J. és mtsai: C-reactive protein: structural biology and host defense function. Clin. Chem. Lab. Med, 1999, 37, 265-270.
35. Tracy, R. P., Lemaitre, R. N., Psaty, B. M. és mtsai: Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler. Thromb. Vasc. Biol., 1997, 17, 1121-1127.
36. Veres, A., Füst, G., Smieja, M. és mtsai: Relationship of anti-60 kDa heat shock protein and anti-cholesterol antibodies to cardiovascular events. Circulation, 2002, 106, 2775-2784.